A Randomized, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina in Adult Patients With Diabetic Macular Edema

Trial Profile

A Randomized, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina in Adult Patients With Diabetic Macular Edema

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs Danazol (Primary)
  • Indications Diabetic macular oedema
  • Focus Registrational; Therapeutic Use
  • Acronyms OptimEyes
  • Sponsors Ampio Pharmaceuticals
  • Most Recent Events

    • 04 Oct 2016 According to an Ampio Pharmaceuticals media release, results of this trial were presented at the World Congress of Ophthalmology and 2016 annual meeting of the Retina Society.
    • 04 Oct 2016 Results published in an Ampio Pharmaceuticals Media Release
    • 04 Oct 2016 Data from this trial was accepted for publication in Acta Ophthalmologica, according to an Ampio Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top